A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies

Volunteers
Health Professionals

What is the purpose of this trial?

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Michael Hurwitz

michael.hurwitz@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Michael Hurwitz, MD, PhD
Associate Professor of Internal Medicine (Medical Oncology)

Sub-Investigators

Last Updated
08/02/2024
Study HIC
#2000034666